Article
Early immunomodulatory program triggered by pro-tolerogenic <i>Bifidobacterium pseudolongum</i> drives cardiac transplant outcomes
2022-10-16
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Despite ongoing improvements in regimens to prevent allograft rejection, most cardiac and other organ grafts eventually succumb to chronic vasculopathy, interstitial fibrosis, or endothelial changes, and eventually graft failure. The events leading to chronic rejection are still poorly understood and the gut microbiota is a known driving force in immune dysfunction. We previ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bb5a1459-3c31-52ab-ad00-f8910e4e7a3d
- DOI
- 10.1101/2022.10.13.511915
